Nexilico And Siolta Therapeutics Collaborate To Develop Microbiome Therapeutic
17 Sep 2024 //
BUSINESSWIRE
Siolta Raises $12 Million in Series C Financing for Clinical Development
14 Mar 2024 //
BUSINESSWIRE
Siolta Raises $12 Million in Series C Financing for Clinical Development
12 Mar 2024 //
BUSINESSWIRE
Siolta Announces 1st Newborn Dosed in Their PII ADORED Study for Atopic Diseases
20 Jul 2022 //
BUSINESSWIRE
Siolta Therapeutics Awarded NIH Grant
09 Feb 2022 //
BUSINESSWIRE
Bio-Me & Siolta to collaborate on developing microbiome-based pediatric allergy
23 Nov 2020 //
PRNEWSWIRE